Fairmount Funds Management’s Trillium Therapeutics Inc. TRIL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-886,281
| Closed | -$15.6M | – | 21 |
|
|
2021
Q3 | $15.6M | Sell |
886,281
-10,000
| -1% | -$176K | 5.66% | 7 |
|
|
2021
Q2 | $8.69M | Sell |
896,281
-426,900
| -32% | -$4.14M | 3.57% | 12 |
|
|
2021
Q1 | $14.2M | Sell |
1,323,181
-155,000
| -10% | -$1.66M | 5.99% | 6 |
|
|
2020
Q4 | $21.7M | Sell |
1,478,181
-80,000
| -5% | -$1.18M | 7.78% | 5 |
|
|
2020
Q3 | $22.1M | Buy |
1,558,181
+75,000
| +5% | +$1.07M | 9.38% | 3 |
|
|
2020
Q2 | $12M | Sell |
1,483,181
-335,000
| -18% | -$2.71M | 5.35% | 10 |
|
|
2020
Q1 | $7.35M | Buy |
+1,818,181
| New | +$7.35M | 4.45% | 12 |
|